J Koetsveld1, N M Kolyasnikova2, A Wagemakers1, M G Toporkova3, D S Sarksyan4, A Oei1, A E Platonov2, J W Hovius5. 1. Center for Experimental and Molecular Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. 2. Central Research Institute of Epidemiology, Moscow, Russia. 3. Medical Association 'Novaya Bolnitsa', Yekaterinburg, Russia. 4. Izhevsk State Medical Academy, Izhevsk, Udmurt Republic, Russia. 5. Center for Experimental and Molecular Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: lyme@amc.uva.nl.
Abstract
OBJECTIVES: Borrelia miyamotoi has been shown to infect humans in Eurasia and North America causing hard tick-borne relapsing fever (HTBRF). In vitro cultivation of B. miyamotoi was described recently; but clinical isolation of relapsing fever Borrelia is cumbersome. Our aim was to develop a straightforward protocol enabling B. miyamotoi isolation directly from the blood of patients. METHODS: Modified Kelly-Pettenkorfer (MKP-F) medium, with or without anticoagulants, or blood from healthy human volunteers, was spiked with B. miyamotoi spirochaetes in vitro. Subsequently, either media or plasma was used for cultivation directly, or after an additional centrifugation step. This isolation protocol was tested in a clinical setting on patients suspected of HTBRF. RESULTS: Dipotassium-EDTA, trisodium citrate and lithium heparin inhibited growth of B. miyamotoi at concentrations ≥250 μg/mL, 2.5 mM and 1 IU/mL, respectively. However, when plasma originating from human blood containing B. miyamotoi spirochaetes was subjected to an additional centrifugation step at 8000 g, suspended and inoculated into fresh MKP-F media, positive cultures were observed within 2 weeks. Of importance, this straightforward protocol allowed for isolation of B. miyamotoi from six out of nine patients with confirmed HTBRF. CONCLUSIONS: Direct culture from K2-EDTA, trisodium citrate and lithium heparin plasma containing B. miyamotoi is hampered due to anticoagulants. Using a simple centrifugation protocol we were able to circumvent this detrimental effect, allowing for the first clinical isolation of B. miyamotoi. This will be of value for future research on the pathogenesis, genetics, diagnosis, therapy and epidemiology of HTBRF and other tick-borne relapsing fevers.
OBJECTIVES:Borrelia miyamotoi has been shown to infect humans in Eurasia and North America causing hard tick-borne relapsing fever (HTBRF). In vitro cultivation of B. miyamotoi was described recently; but clinical isolation of relapsing fever Borrelia is cumbersome. Our aim was to develop a straightforward protocol enabling B. miyamotoi isolation directly from the blood of patients. METHODS: Modified Kelly-Pettenkorfer (MKP-F) medium, with or without anticoagulants, or blood from healthy human volunteers, was spiked with B. miyamotoi spirochaetes in vitro. Subsequently, either media or plasma was used for cultivation directly, or after an additional centrifugation step. This isolation protocol was tested in a clinical setting on patients suspected of HTBRF. RESULTS:Dipotassium-EDTA, trisodium citrate and lithium heparin inhibited growth of B. miyamotoi at concentrations ≥250 μg/mL, 2.5 mM and 1 IU/mL, respectively. However, when plasma originating from human blood containing B. miyamotoi spirochaetes was subjected to an additional centrifugation step at 8000 g, suspended and inoculated into fresh MKP-F media, positive cultures were observed within 2 weeks. Of importance, this straightforward protocol allowed for isolation of B. miyamotoi from six out of nine patients with confirmed HTBRF. CONCLUSIONS: Direct culture from K2-EDTA, trisodium citrate and lithium heparin plasma containing B. miyamotoi is hampered due to anticoagulants. Using a simple centrifugation protocol we were able to circumvent this detrimental effect, allowing for the first clinical isolation of B. miyamotoi. This will be of value for future research on the pathogenesis, genetics, diagnosis, therapy and epidemiology of HTBRF and other tick-borne relapsing fevers.
Authors: Annemijn Manger; Dieuwertje Hoornstra; Joris Koetsveld; Ronald O Draga; Anneke Oei; Nadezhda M Kolyasnikova; Marina G Toporkova; Denis S Sarksyan; Alex Wagemakers; Alexander E Platonov; Joppe W Hovius Journal: Antimicrob Agents Chemother Date: 2018-06-26 Impact factor: 5.191
Authors: Konstantin V Kuleshov; Gabriele Margos; Volker Fingerle; Joris Koetsveld; Irina A Goptar; Mikhail L Markelov; Nadezhda M Kolyasnikova; Denis S Sarksyan; Nina P Kirdyashkina; German A Shipulin; Joppe W Hovius; Alexander E Platonov Journal: BMC Genomics Date: 2020-01-06 Impact factor: 3.969
Authors: Konstantin V Kuleshov; Joris Koetsveld; Irina A Goptar; Mikhail L Markelov; Nadezhda M Kolyasnikova; Denis S Sarksyan; Marina G Toporkova; Nina P Kirdyashkina; German A Shipulin; Joppe W Hovius; Alexander E Platonov Journal: Genome Announc Date: 2018-01-04
Authors: Sally Cutler; Muriel Vayssier-Taussat; Agustín Estrada-Peña; Aleksandar Potkonjak; Andrei Daniel Mihalca; Hervé Zeller Journal: Euro Surveill Date: 2019-05
Authors: Adam J Replogle; Christopher Sexton; John Young; Luke C Kingry; Martin E Schriefer; Marc Dolan; Tammi L Johnson; Neeta P Connally; Kerry A Padgett; Jeannine M Petersen Journal: Sci Rep Date: 2021-01-21 Impact factor: 4.996